Manufacturer record

Brij Healthcare Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Brij Healthcare Pvt. Ltd (Gujarat) were declared Not of Standard Quality between June 2024 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: 2411110, Levocetirizine Dihydrochloride Tablets IP 5 mg (Alercet-5) (exp Oct 2026). CDTL Indore (CDSCO lab) found it not of standard quality: Dissolution. Listed in the February 2025 alert.

Records by type

2 records linked to Brij Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2024 to Feb 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
2
Products affected
Dissolution
Most common failure
Feb 2025
Latest alert

Flagged batches per year

2024 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levocetirizine Dihydrochloride Tablets IP 5 mg (Alercet-5) Batch 2411110Mfg Nov 2024 · Exp Oct 2026 DissolutionDissolution CDTL IndoreCDSCO lab Feb 2025
Extuss-D (Dextromethorp han HBR, Chlorpheniramin e Maleate & Phenylephrine HCL Syrup) Batch 2402168Mfg Feb 2024 · Exp Jan 2026 Assay of Phenylephrin e HydrochlorideAssay CDTL MumbaiCDSCO lab Jun 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.